{"transactions":[{"id":4616526,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-09-12T00:14:00.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":62000,"price":5.1803,"value":321178.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026."}],"balance_after":35475,"source":{"system":"sec-edgar","filing":"0001193125-26-389564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000119312526389564/ownership.xml","form_type":"4"}},{"id":4616525,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.00001 per share","published_at":"2026-09-12T00:14:00.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":14754,"price":5.0006,"value":73778.8524,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 reflects the weighted-average sales price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0007, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,745 shares of common stock acquired pursuant to the Issuer's 2025 Employee Stock Purchase Plan on May 22, 2026."}],"balance_after":97475,"source":{"system":"sec-edgar","filing":"0001193125-26-389564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000119312526389564/ownership.xml","form_type":"4"}},{"id":910241,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-02-11T21:00:21.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":false,"shares":70549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 9, 2027, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive."}],"balance_after":70549,"derivative":{"exercise_price":13.48,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":70549},"source":{"system":"sec-edgar","filing":"0001193125-26-047317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000119312526047317/ownership.xml","form_type":"4"}},{"id":971563,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-12T20:30:05.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":14.4,"value":43200.0,"ownership":{"direct":true},"balance_after":108484,"source":{"system":"sec-edgar","filing":"0001193125-25-318070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000119312525318070/ownership.xml","form_type":"4"}},{"id":1044178,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-10T17:36:04.000Z","date":"2025-09-09","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":8.0733,"value":48439.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.00 to $8.20 per share, inclusive. The reporting person undertakes to provide Aardvark Therapeutics, Inc. (\"Aardvark\"), any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":105484,"source":{"system":"sec-edgar","filing":"0001193125-25-200226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000119312525200226/ownership.xml","form_type":"4"}},{"id":1112146,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T16:05:08.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":209826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on June 11, 2026, and 1/48th of the shares subject to the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date, inclusive."}],"balance_after":209826,"derivative":{"exercise_price":11.29,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":209826},"source":{"system":"sec-edgar","filing":"0000950170-25-086143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000095017025086143/ownership.xml","form_type":"4"}},{"id":1260774,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-02-19T16:30:49.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":59332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7001},"source":{"system":"sec-edgar","filing":"0000950170-25-023243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000095017025023243/ownership.xml","form_type":"4"}},{"id":1260773,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T16:30:49.000Z","date":"2025-02-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":16,"value":160000.0,"ownership":{"direct":true},"balance_after":99484,"source":{"system":"sec-edgar","filing":"0000950170-25-023243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000095017025023243/ownership.xml","form_type":"4"}},{"id":1260772,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":66913,"kind":"person","name":"Sun Nelson","position":1,"cik":"0002045377","reported_name":"Sun Nelson","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T16:30:49.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":7001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."}],"balance_after":89484,"source":{"system":"sec-edgar","filing":"0000950170-25-023243","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2045377/000095017025023243/ownership.xml","form_type":"4"}}]}